Product
Supplier
Encyclopedia
Inquiry
Home > Chemical Reagents > Organic Reagents > ((3S,4R)-3-Amino-4-hydroxypiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-indol-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride for Sale > GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - large image1
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - image1
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - image2
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - image3
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - image4
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - image5
GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research buy - image6

GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research

Unit Price: Get Latest Price
CAS No.:

1652591-81-5

Grade:

Reagent Grade

Content:

99%

Port:

qingdao

Brand:

//

Packaging:

bag

Sample Available:

Yes

Price valid (until):

2026-08-03

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524

  • Product Details

  • Seller Information

  • Description

    1. Product Overview

    GSK484 hydrochloride (CAS: 1652591-81-5) is a potent, selective, and reversible benzimidazole-derived inhibitor of peptidylarginine deiminase 4 (PAD4, also known as PADI4). As a hydrochloride salt form optimized for research use, it targets the calcium-sensitive PAD4 enzyme responsible for citrullination — the post-translational conversion of arginine residues to citrulline on histone tails and other substrates. With an IC₅₀ of 50 nM in the absence of calcium and 250 nM in the presence of 2 mM calcium, GSK484 provides researchers with a precise pharmacological tool to dissect PAD4-mediated pathways in rheumatoid arthritis, lupus, cancer-associated inflammation, and neutrophil extracellular trap (NET) formation (NETosis). Unlike irreversible pan-PAD inhibitors, GSK484’s reversible binding kinetics and high isoform selectivity make it the gold-standard probe for mechanistic studies of protein citrullination.

    2. Key Features and Advantages

    • High Selectivity Profile: Exhibits >50-fold selectivity for PAD4 over other PAD isoforms (PAD1, PAD2, PAD3) at working concentrations, minimizing off-target citrullination effects in complex cellular systems.

    • Reversible Inhibition Mechanism: Binds reversibly to the low-calcium conformation of PAD4, allowing temporal control of inhibition in washout experiments and dynamic pathway dissection.

    • Calcium-Dependent Activity: Displays pronounced calcium sensitivity (IC₅₀ shifts from 50 nM at 0 mM Ca²⁺ to 250 nM at 2 mM Ca²⁺), faithfully mimicking physiological PAD4 regulation and enabling calcium-gated assay designs.

    • Research-Grade Consistency: Supplied at ≥98% purity (HPLC), with full structural verification by ¹H NMR, LC-MS, and elemental analysis; batch-specific CoA provided for reproducibility across Western blot, ELISA, and in vivo studies.

    • Proven In Vivo Efficacy: Documented to suppress NETosis and reduce proteinuria in MMTV-PyMT tumor-bearing mice at 4 mg/kg/day without detectable toxicity, supporting its use in preclinical rodent models.

    • Optimized Salt Form: The hydrochloride salt enhances aqueous solubility (≈2 mg/mL in warmed water; 25 mg/mL in DMSO) and solid-state stability compared to the free base, simplifying both in vitro and in vivo formulation.

    3. Main Applications

    • Autoimmune Disease Research: Widely used in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) models to investigate how PAD4-driven citrullination of fibrinogen, vimentin, and histones generates anti-citrullinated peptide antibodies (ACPAs) and drives joint inflammation.

    • NETosis & Innate Immunity Studies: Applied in primary human/mouse neutrophil assays (immunofluorescence, live-cell imaging, ELISA for MPO-DNA complexes) to quantify NET release and evaluate PAD4’s role in infection, sepsis, thrombosis, and COVID-19-associated immunothrombosis.

    • Oncology & Tumor Microenvironment: Employed in cancer models (e.g., MMTV-PyMT breast cancer, colorectal carcinoma) to study PAD4-mediated neutrophil recruitment, metastatic niche formation, and tumor-promoted kidney injury via NET-dependent mechanisms.

    • Epigenetics & Chromatin Biology: Used in histone citrullination tracking (citH3 Arg2/8/17 Western blots) to distinguish PAD4-dependent chromatin remodeling from other post-translational modifications during gene activation or cellular differentiation.

    • High-Throughput Screening Counter-Screen: Serves as a selective reference inhibitor in PAD4-targeted drug discovery campaigns and orthogonal validation of novel irreversible or allosteric PAD4 probes.

    • In Vivo Pharmacodynamics: Administered intraperitoneally or orally in mice (typical dose 4–10 mg/kg/day) to assess urinary protein reduction, circulating NET markers, and synovial citrullination in disease models.

    4. Technical Specifications

    Shop GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research-Detailed Image 1

    5. Storage and Handling

    • Powder Storage: Store the sealed original vial at 2–8°C in a refrigerator, protected from light and moisture with desiccant present. Under these conditions the powder remains stable for at least 24 months. For archival storage (>2 years), a -20°C freezer with inert atmosphere is recommended.

    • Reconstitution: Allow the vial to equilibrate to room temperature before opening to prevent moisture condensation. Briefly centrifuge to collect material. For in vitro assays, dissolve in anhydrous DMSO to prepare a 10–25 mM stock solution (clear upon gentle vortexing/sonication). For in vivo studies, GSK484 can be dissolved in warm PBS (≈2 mg/mL) or formulated in 5% DMSO + 95% corn oil / saline with mild warming.

    • Solution Storage: Aliquot DMSO stocks into single-use volumes (e.g., 10–50 µL) immediately after preparation. Store aliquots at -20°C (short-term, ≤6 months) or -80°C (long-term, up to 12 months). Strictly avoid repeated freeze-thaw cycles; thaw only the required aliquot on ice before use.

    • Handling Precautions: Use in a well-ventilated area or fume hood. Wear nitrile gloves, safety goggles, and a lab coat. Minimize dust generation; do not inhale powder. Keep container tightly closed when not in use.

    6. Safety Overview

    GSK484 hydrochloride is intended strictly for Laboratory Research Use Only (LRUO). It is not for human or veterinary diagnostic, therapeutic, or consumable use. Classified under GHS07 with warning label: H302 (Harmful if swallowed), H315 (Causes skin irritation), H319 (Causes serious eye irritation), H335 (May cause respiratory irritation). In case of contact with skin, wash immediately with plenty of soap and water. In case of eye contact, rinse cautiously with flowing water for at least 15 minutes and seek medical advice. If inhaled, move to fresh air. Dispose of as hazardous organic chemical waste per local regulations (WGK 3, environmentally hazardous). Always consult the full Safety Data Sheet (SDS) prior to handling.Shop GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research-Detailed Image 2 Shop GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research-Detailed Image 3 Shop GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research-Detailed Image 4 Shop GSK484 CAS 1652591-81-5 98% White to Beige Powder Selective Reversible PAD4 Inhibitor for Inflammation, Autoimmunity & NETosis Research-Detailed Image 5

    Basic Info
    Product Name:

    ((3S,4R)-3-Amino-4-hydroxypiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-indol-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride

    CAS No.:

    1652591-81-5

    Categories:

    Organic Reagents

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524

    Location:

    RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2022

    Jinan Topfull Chemical Co., Ltd. is a global chemical Industrial and focuses on advanced chemical technology. Specialized in Cosmetic materials, water treatment, fine chemicals and so on. We are looking forward to working together with the people of all circles at home and abroad to seek common development!
  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.